This multi-centre, multi-national, prospective, observational registry is now launched and will:
- Focus on specific participating sites which have been selected from the major transplant centres (defined as those performing at least 100 transplants per year)
- Be open to enrolment until June 2017. It is planned to recruit 300 patients treated with Defitelio® and 300 patients managed through supportive care only who will act as a control group
- Collect data on serious adverse events (SAEs) of interest as well as endpoints of interest in relation to clinical outcome and standard baseline information
In addition to the selected participating sites, EBMT would be open to consider additional transplant centres across Europe who may be interested in contributing data to this registry. (Please note that further approvals at a European and a national level may be required for participation of additional sites in the Registry.)
Participants who want to report data in the VOD Registry must click on the following link to the logon page. Please be sure that you have your log in credentials.